Itau Unibanco Holding S.A. 4 D Molecular Therapeutics, Inc. Transaction History

Itau Unibanco Holding S.A.

  • $2.95 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$9.76 - $21.25 $1,434 - $3,123
147 Added 9.81%
1,646 $33,000
Q3 2023

Nov 14, 2023
BUY
$12.64 - $19.76 $4,626 - $7,232
366 Added 32.3%
1,499 $19,000
Q2 2023

Aug 14, 2023
BUY
$15.16 - $23.26 $17,176 - $26,353
1,133 New
1,133 $20,000

Others Institutions Holding FDMT

# of Institutions
144
Shares Held
57.7M
Call Options Held
137K
Put Options Held
111K
View Full List

About 4D Molecular Therapeutics, Inc.

FDMT Quotes by TradingView
  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $252M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Itau Unibanco Holding S.A. Portfolio

Follow Itau Unibanco Holding S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Itau Unibanco Holding S.A., based on Form 13F filings with the SEC.

News

Stay updated on Itau Unibanco Holding S.A. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email